Yanoset Tablet is a combination analgesic formulation containing Tramadol 37.5 mg and Paracetamol 325 mg, designed for the management of moderate to moderately severe pain. Tramadol, a centrally acting opioid analgesic, exerts its effect by binding to the μ-opioid receptor and inhibiting the reuptake of norepinephrine and serotonin, thereby modulating pain perception. Paracetamol, a non-opioid analgesic and antipyretic agent, enhances the analgesic effect through inhibition of prostaglandin synthesis in the central nervous system. The synergistic action of these two active ingredients provides effective pain relief with a potentially reduced opioid dosage, minimizing the risk of opioid-related adverse effects. Yanoset Tablet is indicated for conditions such as musculoskeletal pain, postoperative pain, dental pain, and other acute pain states requiring combination therapy. It should be used with caution in patients with hepatic or renal impairment, a history of substance abuse, or seizure disorders. Common adverse effects may include nausea, dizziness, constipation, and somnolence. Yanoset Tablet is contraindicated in patients with hypersensitivity to tramadol, paracetamol, or any component of the formulation, and in those receiving monoamine oxidase inhibitors. Proper dosing and adherence to prescribed guidelines are essential to ensure safety and efficacy.